NCT04220112

Brief Summary

The goal of the purposed research is to extend prior work (STUDY00003758: Real-time fMRI Neurofeedback to Alter Limbic Disturbances in Anorexia Nervosa) on real-time fMRI (rt-fMRI) neurofeedback (focused on amygdala down-regulation) as an innovative neurocircuitry-targeted intervention for anorexia nervosa (AN). This project will include randomization to rt-fMRI or a sham controlled group to answer the following important unresolved question: Does a patient-led procedure aimed at altering brain activity impact limbic circuit function and key eating disorder and psychiatric symptoms in AN above the effect of a matched, but non-targeted sham condition?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 3, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 7, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

March 1, 2020

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2022

Completed
Last Updated

December 1, 2022

Status Verified

November 1, 2022

Enrollment Period

2.4 years

First QC Date

January 3, 2020

Last Update Submit

November 29, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change in Eating Disorder Symptoms Scale (CHEDS)

    CHEDS is a 35-item self-report measure designed to assess eating disorder symptom changes over a short-term (i.e. weekly) time span. Items are presented using a Likert response format in which symptoms are rated from 0 (never) to 4 (always) during the past week. Total score is a sum of the 35 item scores.

    2 months

  • Change in Body Mass Index (BMI)

    Change in body mass index (BMI) from baseline to end (2 months). BMI is calculated as body weight (in kg) divided by height (in cm) squared. BMI is reported in kg/(cm\^2).

    2 months

  • Test Meal Caloric Intake

    Caloric consumption (in kilocalories) from a laboratory test meal

    2 months

Study Arms (2)

Real Time Functional MRI (rt-fMRI)

EXPERIMENTAL

Real-time fMRI (rt-fMRI) neurofeedback (focused on amygdala down-regulation) intervention

Procedure: Real-Time Functional Magnetic Resonance Imaging (RT-fMRI)

Sham

SHAM COMPARATOR

Sham-controlled group

Procedure: Sham Procedure

Interventions

RT-fMRI neurofeedback targeting down-regulation of the amygdala

Real Time Functional MRI (rt-fMRI)

RT-fMRI with feedback non-contingently tied to their activation patterns (activation patterns from a prior participant)

Sham

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • DSM-5 diagnosis of AN, with the exception of body image disturbance and intense fear of weight gain
  • Ability to read and speak in English
  • Right-handed

You may not qualify if:

  • Medical instability or current pregnancy (self-reported)
  • Acute suicidality, current substance use disorder, psychosis, or mania
  • Contraindication for fMRI as determined by CMRR safety screening standards
  • History of neurological disorder/injury (e.g., stroke; head injury with \> 10 minutes loss of consciousness)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Minnesota

Minneapolis, Minnesota, 55455, United States

Location

MeSH Terms

Conditions

AnorexiaAnorexia Nervosa

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsFeeding and Eating DisordersMental Disorders

Study Officials

  • Ann Haynos, PhD

    University of Minenesota

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 3, 2020

First Posted

January 7, 2020

Study Start

March 1, 2020

Primary Completion

July 31, 2022

Study Completion

September 30, 2022

Last Updated

December 1, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations